Neuronetics, Inc.
STIM
$1.39
-$0.03-2.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.13% | 19.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.13% | 19.18% | |||
| Cost of Revenue | -0.79% | 25.33% | |||
| Gross Profit | -3.66% | 12.84% | |||
| SG&A Expenses | -4.55% | -4.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.35% | 7.39% | |||
| Operating Income | 9.15% | 26.84% | |||
| Income Before Tax | 4.45% | 22.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.45% | 22.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 226.69% | -2,107.14% | |||
| Net Income | 10.62% | 20.16% | |||
| EBIT | 9.15% | 26.84% | |||
| EBITDA | 10.09% | 29.16% | |||
| EPS Basic | 12.10% | 25.85% | |||
| Normalized Basic EPS | 15.64% | 24.53% | |||
| EPS Diluted | 12.10% | 25.85% | |||
| Normalized Diluted EPS | 15.64% | 24.53% | |||
| Average Basic Shares Outstanding | 1.71% | 7.67% | |||
| Average Diluted Shares Outstanding | 1.71% | 7.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||